Achem-block can design, synthesize and collect structurally diverse monomers, scaffolds and intermediates, based on the cutting-edge reactions from academic journals and core structures from clinical and preclinical drugs. The focus on the unique and novel structures makes BB2.0 series of Achem-block the best match of your drug discovery.

Our catalogue currently contains 200,000 building blocks including 100,000 compounds in stock, which can be delivered within 1-7 days from our global logistics centers in China and Europe.